What was tested
Researchers randomized 84 participants to reishi, reishi with Cordyceps sinensis, or placebo. The active regimens supplied 3 grams of reishi daily; their results were pooled for analysis. [1]
Neither glycated hemoglobin nor fasting glucose improved relative to placebo. Secondary outcomes were also negative. This matters because the primary outcomes were defined measures, not a general impression of better health. [1]
How far the result applies
Pooling the two active regimens limits conclusions about their individual differences. The study concerns its preparations and population; it cannot establish the effect of every mushroom product. It also does not justify replacing diabetes treatment. Funding and conflicts were not established from the retrieved abstract. [1]
A hypothetical reading of the evidence
Imagine an advertisement promises better glucose control. A laboratory mechanism would not override a negative controlled clinical result for the tested regimen.
| Detail | Interpretation |
|---|---|
| Study result | Limited to its measured outcomes |
| Other preparation | Equivalence not established |
| Broader claim | Needs separate evidence |
Sources for this article
- A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.